Updated Jul 16, 2026
Dalton Angela is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Angela Dalton is a director at 180 Life Sciences Corp., a company focused on developing therapies for chronic pain and inflammation. Information about her prior experience and achievements is limited.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-07 | FRMM | FORUM MARKETS Inc | A — Grant or award | 203.6K | $0.00 |
Angela Dalton is a director at 180 Life Sciences Corp., a company focused on developing therapies for chronic pain and inflammation. Information about her prior experience and achievements is limited.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dalton Angela profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.